Cargando…

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer compared to other subtypes of breast cancer

PURPOSE: The aim of this study was to compare the accuracy of magnetic resonance imaging (MRI) for the prediction of response to neo-adjuvant chemotherapy in triple negative (TN) breast cancer, with respect to other subtypes. MATERIALS AND METHODS: There were a total of 1610 breast cancers diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bansal, Gaurav J, Santosh, Divya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Women Imaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201078/ https://www.ncbi.nlm.nih.gov/pubmed/28104942 http://dx.doi.org/10.4103/0971-3026.195793

Ejemplares similares

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors
por: Sohn, Yu-Mee, et al.
Publicado: (2016)

Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions
por: Liu, Li, et al.
Publicado: (2016)

Utility of supplemental screening with breast ultrasound in asymptomatic women with dense breast tissue who are not at high risk for breast cancer
por: Klevos, Geetika A, et al.
Publicado: (2017)

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
por: Bhattacharyya, G. S., et al.
Publicado: (2018)

Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy
por: Mori, Miki, et al.
Publicado: (2019)

Takeaways from Pre-Contrast T1 and T2 Breast Magnetic Resonance Imaging in Women with Recently Diagnosed Breast Cancer
por: Han, Seung Hee, et al.
Publicado: (2016)

Desmoid Tumor of the Chest Wall Mimicking Recurrent Breast Cancer: Multimodality Imaging Findings
por: Choi, Kyeong A, et al.
Publicado: (2016)

Radiologic Findings of Ductal Carcinoma in Situ Arising Within a Juvenile Fibroadenoma: Mammographic, Sonographic and Dynamic Contrast-Enhanced Breast MRI Features
por: Park, Eun Kyung, et al.
Publicado: (2015)

Nodular Fasciitis of the Breast
por: Moghimi, Mansour, et al.
Publicado: (2016)

Additional Value of Diffusion-Weighted Imaging to Evaluate Prognostic Factors of Breast Cancer: Correlation with the Apparent Diffusion Coefficient
por: Park, Eun Kyung, et al.
Publicado: (2016)

Isolated eosinophilic infiltration of the breast
por: Parakh, Anushri, et al.
Publicado: (2016)

Interobserver and Intraobserver Agreement of Sonographic BIRADS Lexicon in the Assessment of Breast Masses
por: Elverici, Eda, et al.
Publicado: (2013)

Breast Filariasis Diagnosed by Real Time Sonographic Imaging: A Case Report
por: Sherwani, Poonam, et al.
Publicado: (2016)

A Rare Case of Invasive Apocrine Carcinoma of the Breast with Unusual Radiologic Findings
por: Min Kim, Ji, et al.
Publicado: (2016)

Diagnostic Value of Pelvic MRI for Assessment of the Depth of Myometrial Invasion and Cervical Involvement in Endometrial Cancer: Comparison of New Versus Old FIGO Staging
por: Zamani, Fatemeh, et al.
Publicado: (2012)

Imaging Features of Breast Dermatofibrosarcoma Protuberans in Various Modalities Including FDG-PET CT
por: Bae, Suk Hyun, et al.
Publicado: (2016)

Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
por: Bianco, Nadia, et al.
Publicado: (2021)

Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine
por: Asleh, Karama, et al.
Publicado: (2023)

Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis
por: Cha, Yoon Jin, et al.
Publicado: (2022)

The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer
por: Chintamani, et al.
Publicado: (2007)

Variability in Observer Performance Between Faculty Members and Residents Using Breast Imaging Reporting and Data System (BI-RADS)-Ultrasound, Fifth Edition (2013)
por: Lee, Youn Joo, et al.
Publicado: (2016)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
por: Schroyen, Gwen, et al.
Publicado: (2023)

A Case of a Concurrent and Co-Located Invasive Carcinoma and a Fibroadenoma to Illustrate the Potential of Dual-Energy, Contrast-Enhanced Digital Mammography on the Diagnosis of Complex Breast Lesions
por: Travieso Aja, Maria Del Mar, et al.
Publicado: (2016)

Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast
por: Belzer, Annika, et al.
Publicado: (2022)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin
por: Yeo, Winnie, et al.
Publicado: (2022)

Role of apparent diffusion coefficient as a biomarker in the evaluation of cervical cancer
por: Dashottar, Sunita, et al.
Publicado: (2019)

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
por: Tang, Yiqing, et al.
Publicado: (2012)

Optimizing (neo)adjuvant treatment of HER2-positive breast cancer
por: Basho, Reva K., et al.
Publicado: (2018)

A systematic review of neo-adjuvant radiotherapy in the treatment of breast cancer
por: Ahmed, Muneer, et al.
Publicado: (2021)

[(18)F]FDG and [(18)F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
por: Raccagni, Isabella, et al.
Publicado: (2018)

An immune surveillance model to monitor the response to neo-adjuvant chemotherapy treatment in breast cancer patients
por: Bernal-Estévez, David A, et al.
Publicado: (2015)

Isolated Leptomeningeal Metastasis of Breast Cancer During Neo-Adjuvant Chemotherapy: A Case Report
por: Uddin, Aaliya, et al.
Publicado: (2022)

Sigmoid model analysis of breast dynamic contrast‐enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction
por: Koori, Norikazu, et al.
Publicado: (2022)

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
por: Lluch, Ana, et al.
Publicado: (2020)

Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer? -A prospective clinical study
por: Chintamani, et al.
Publicado: (2004)

Morphological Estimation of Cellularity on Neo-Adjuvant Treated Breast Cancer Histological Images
por: Ortega-Ruiz, Mauricio Alberto, et al.
Publicado: (2020)

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h68spoekb6ku0kbvhe4km2q9qv